Novartis Rhapsido gets USFDA nod for chronic spontaneous urticaria We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis commences tender offer to buy Tourmaline Bio We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis, Monte Rosa Therapeutics join hands for Degraders to treat Immune-mediated diseases We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis to buy Tourmaline Bio for USD 1.4 billion We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis Leqvio shows statistically significant, clinically meaningful early LDL-C goal achievement with less muscle pain We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopenia We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Novartis eyes Avidity Biosciences in potential takeover: Report We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
